Mueggler Thomas, Sturchler-Pierrat Christine, Baumann Diana, Rausch Martin, Staufenbiel Matthias, Rudin Markus
Central Technologies, Novartis Pharma, AG, CH-4002 Basel, Switzerland.
J Neurosci. 2002 Aug 15;22(16):7218-24. doi: 10.1523/JNEUROSCI.22-16-07218.2002.
APP23 transgenic mice overexpressing amyloid precursor protein (APP751) reproduce neuropathological changes associated with Alzheimer's disease such as high levels of amyloid plaques, cerebral amyloid angiopathy, and associated vascular pathologies. Functional magnetic resonance imaging (fMRI) was applied to characterize brain functionality in these mice through global pharmacological stimulation. The cerebral hemodynamic response to infusion of the GABA(A) antagonist bicuculline was significantly reduced in aged APP23 mice compared with age-matched wild-type littermates. This is in part attributable to a compromised cerebrovascular reactivity, as revealed by the reduced responsiveness to vasodilatory stimulation by acetazolamide. The study shows that fMRI is a sensitive tool to phenotype genetically engineered animals modeling neuropathologies.
过度表达淀粉样前体蛋白(APP751)的APP23转基因小鼠会重现与阿尔茨海默病相关的神经病理学变化,如高水平的淀粉样斑块、脑淀粉样血管病及相关血管病变。应用功能磁共振成像(fMRI)通过全身性药理刺激来表征这些小鼠的脑功能。与年龄匹配的野生型同窝小鼠相比,老年APP23小鼠对注入γ-氨基丁酸A(GABA(A))拮抗剂荷包牡丹碱的脑血流动力学反应显著降低。这部分归因于脑血管反应性受损,这可通过乙酰唑胺对血管舒张刺激的反应性降低来揭示。该研究表明,fMRI是对模拟神经病理学的基因工程动物进行表型分析的一种灵敏工具。